Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: Differential impact of μ and δ receptor activation on proliferation and neurite elongation

European Journal of Neuroscience

Volumn 12, Issue 4, 2000, Pages 1281-1293

  Hauser, Kurt F ^a   Houdi, Abdulghani A ^b   Turbek, Carol S ^a   Elde, Robert P ^c   Maxson III, William ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

opioid receptors; opioid receptors; Apoptosis; Cell division; Cerebellar development; Endogenous opioid system; Neuronal differentiation; Opiate drug abuse

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE; PROENKEPHALIN;

ANIMAL CELL; ARTICLE; BRAIN MATURATION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBELLUM; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ABUSE; LIGAND BINDING; MOUSE; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; ANTIMETABOLITES; APOPTOSIS; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DNA; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, METHIONINE; ENKEPHALINS; MICE; MICROSCOPY, ELECTRON; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NEURITES; NEURONS; OLIGOPEPTIDES; OPIOID-RELATED DISORDERS; PROTEIN PRECURSORS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; STEM CELLS;

EID: 0034053006     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.01015.x     Document Type: Article

References (106)

1. Akil, H., Watson, S.J., Young, E., Lewis, M.E., Khachaturian, H. & Walker, J.M. (1984) Endogenous opioids: biology and function. Annu. Rev. Neurosci., 7, 223-255.
2. Altman, J. (1972) Postnatal development of the cerebellar cortex in the rat. I. The external germinal layer and the transitional molecular layer. J. Comp. Neurol., 145, 353-398.
3. Arvidsson, U., Dado, R.J., Riedl, M., Lee, J.-H., Law, P.Y., Loh, H.H., Elde, R. & Wessendorf, M.W. (1995b) δ-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J. Neurosci., 15, 1215-1235.
4. Arvidsson, U., Riedl, M., Chakrabarti, S., Lee, J.-H., Nakano, A.H., Dado, R.J., Loh, H.H., Law, P.-Y., Wessendorf, M.W. & Elde, R. (1995a) Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci., 15, 3328-3341.
5. Arvidsson, U., Riedl, M., Chakrabarti, S., Vulchanova, L., Lee, J.-H., Nakano, A.H., Lin, X., Loh, H.H., Law, P.-Y., Wessendorf, M.W. & Elde, R. (1995c) The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl Acad. Sci. USA, 92, 5062-5066.
6. Bakalkin, G.Y., Ponomariev, D., Sarkisyan, R.A. & Terenius, L. (1991) Sequence similarity between opioid peptide precursors and DNA-binding proteins. FEBS Lett., 282, 175-177.
7. 5]Enkephalin-encoding sequences are targets for a specific DNA-binding factor. Proc. Natl Acad. Sci. USA, 92, 9024-9028.
8. Barg, J., Belcheva, M.M. & Coscia, C.J. (1992) Evidence for the implication of phosphoinositol signal transduction in μ-opioid inhibition of DNA synthesis. J. Neurochem., 59, 1145-1152.
9. Barg, J., Belcheva, M., McHale, R., Levy, R., Vogel, Z. & Coscia, C.J. (1993) Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu-and kappa-opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem., 60, 765-767.
10. Barr, G.A. & Zadina, J. (1998) Maturation of endomorphin-2-like imunoreactivity in the rat. Int. Narcotics Res. Conf. Abstr., 29, 36.
11. Bartolome, J.V., Alicke, B. & Bartolome, M.B. (1997) Central administration of morphine inhibits brain and liver ornithine decarboxylase activity in neonatal rats: involvement of transcription-and non-transcription-dependent mechanisms. Eur. J. Pharmacol., 331, 145-153.
12. Bartolome, J.V., Bartolome, M.B., Lorber, B.A., Dileo, S.J. & Schanberg, S.M. (1991) Effects of central administration of beta-endorphin on brain and liver DNA synthesis in preweaning rats. Neuroscience, 40, 289-294.
13. Bayon, A., Shoemaker, W.J., Bloom, F.E., Mauss, A. & Guillemin, R. (1979) Perinatal development of the endorphin and enkephalin containing systems of the rat brain. Brain Res., 179, 93-101.
14. Belcheva, M.M., Vogel, Z., Ignatova, E., Avidor-Reiss, T., Zippel, R., Levy, R., Young, E.C., Barg, J. & Coscia, C.J. (1998) Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gβγ subunits. J. Neurochem., 70, 635-645.
15. Bostwick, D.G., Null, W.E., Holmes, D., Weber, E., Barchas, J.D. & Bensch, K.G. (1987) Expression of opioid peptides in tumors. N. Engl. J. Meid., 317, 1439-1443.
16. Böttger, V., Böttger, A., Lane, E.B. & Spruce, B.A. (1995) Comprehensive epitope analysis of monoclonal anti-proenkephalin antibodies using phage display libraries and synthetic peptides: revelation of antibody fine specificities caused by somatic mutations in the variable region genes. J. Mol. Biol., 247, 932-946.
17. Böttger, A. & Spruce, B.A. (1995) Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals. J. Cell Biol., 130, 1251-1262.
18. Brooks, P.J., Funabashi, T., Kleopoulos, S.P., Mobbs, C.V. & Pfaff, D.W. (1993) Cell-specific expression of preproenkephalin intronic heteronuclear RNA in the rat forebrain. Mol. Brain Res., 19, 22-30.
19. Bunikowski, R., Grimmer, I., Heiser, A., Metze, B., Schafer, A. & Obladen, M. (1998) Neurodevelopmental outcome after prenatal exposure to opiates. Eur. J. Pediatr., 157, 724-730.
20. Burt, A.R., Carr, I.C., Mullaney, I., Anderson, N.G. & Milligan, G. (1996) Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse δ opioid receptor in rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. Biochem. J., 320, 227-235.
21. Casini, G., Molnar, M., Davis, B.M. & Bagnoli, P. (1995) Posthatching development of preproenkephalin mRNA-expressing cell populations in the pigeon telencephalon. Dev. Brain Res., 84, 233-244.
22. Chasnoff, I.J., Burns, K.A., Burns, W.J. & Schnoll, S.H. (1986) Prenatal drug exposure: effects on neonatal and infant growth and development. Neurohehav. Toxicol. Teratol., 8, 357-362.
23. Davila-Garcia, M.I. & Azmitia, E.C. (1989) Effects of acute and chronic administration of leu-enkephalin on cultured serotonergic neurons: evidence for opioids as inhibitory neuronal growth factors. Dev. Brain Res., 49, 97-103.
24. Dawson, G., Dawson, S.A. & Goswami, R. (1997) Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11 kappa 7) to apoptosis-inducing drugs by a mechanism that may involve ceramide. J. Neurochem., 68, 2363-2370.
25. DiCicco-Bloom, E., Townes-Anderson, E. & Black, I.B. (1990) Neuroblast mitosis in dissociated culture: regulation and relationship to differentiation. J. Cell Biol., 110, 2073-2086.
26. Erspamer, V. (1992) The opioid peptides of the amphibian skin. Int. J. Dev. Neurosci., 10, 3-30.
27. Evans, C.J. (1993) Diversity among the opioid receptors. In Korenman, S.G. & Barchas, J.D. (eds), Biological Basis of Substance Abuse. Oxford University Press, New York, pp. 31-48.
28. Gao, W.-Q., Heintz, N. & Hatten, M.E. (1991) Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro. Neuron, 6, 705-715.
29. Georges, F., Normand, E., Bloch, B. & Le, M.C. (1998) Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Brain Res. Dev. Brain Res., 109, 187-199.
30. Georgoussi, Z., Merkouris, M., Mullaney, I., Megaritis, G., Carr, C., Zioudrou, C. & Milligan, G. (1997) Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling. Biochim. Biophys. Acta, 1359, 263-274.
31. Goswami, R., Dawson, S.A. & Dawson, G. (1998) Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11 kappa7) neurons. J. Neurochem., 70, 1376-1382.
32. 2+ mobilization, development, and the antiproliferative effect of opioids. Brain Res., 737, 175-187.
33. Hallonet, M. & Alvarado-Mallart, R.M. (1997) The chick/quail chimeric system: a model for early cerebellar development. Perspect. Dev. Neurobiol., 5, 17-31.
34. Hallonet, M.E., Teillet, M.A. & Le, D.N. (1990) A new approach to the development of the cerebellum provided by the quail-chick marker system. Development, 108, 19-31.
35. Hammer, R.P. Jr (1993) Effects of opioids on the developing brain. In Hammer, R.P. Jr (ed.), The Neurobiology of Opiates. CRC Press, Boca Raton, Florida, pp. 1-21.
36. Hatten, M.E. (1985) Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol., 100, 384-396.
37. Hatten, M.E. (1987) Neuronal inhibition of astroglial cell proliferation is membrane mediated. J. Cell Biol., 104, 1353-1360.
38. Hauser, K.F. (1992) Morphine regulates DNA synthesis in cerebellar neuroblasts in vitro. Dev. Brain Res., 70, 291-297.
39. Hauser, K.F. & Mangoura, D. (1998) Diversity of the endogenous opioid system in development: novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. Perspect. Dev. Neurobiol., 5, 337-449.
40. Hauser, K.F., McLaughlin, P.J. & Zagon, I.S. (1989) Endogenous opioid systems and the regulation of dendritic growth and spine formation. J. Comp. Neurol., 281, 13-22.
41. Hauser, K.F. & Stiene-Martin, A. (1993) Opiates and the regulation of nervous system development: evidence from in vitro studies. In Hammer, R.P. Jr (ed.), Neurobiology of Opiates. CRC Press, Boca Raton, Florida, pp. 23-61.
42. 2+-dependent mechanism. Brain Res., 720, 191-203.
43. Huang, L.-Y.M. (1995) Cellular mechanisms of excitatory and inhibitory actions of opioids. In Tseng, L.F. (ed.), The Pharmacology of Opioid Peptides. Harwood Academic, Australia, pp. 131-149.
44. Huntley, G.W., Hendry, S.H.C., Killackey, H.P., Chalupa, L.M. & Jones, E.G. (1988) Temporal sequence of neurotransmitter expression by developing neurons of fetal monkey visual cortex. Dev. Brain Res., 43, 69-96.
45. Hutchings, D.E. (1982) Methadone and heroin during pregnancy: a review of behavioral effects in human and animal offspring. Neurobehav. Toxicol. Teratol., 4, 429-434.
46. Ignatova, E.G., Belcheva, M.M., Bohn, L.M., Neuman, M.C. & Coscia, C.J. (1999) Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J. Neurosci., 19, 56-63.
47. Kampa, M., Bakogeorgou, E., Hatzoglou, A., Damianaki, A., Martin, P.M. & Castanas, E. (1997) Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU 145) through a partial interaction with opioid receptors. Eur: J. Pharmacol., 335, 255-265.
48. Kinney, H.C. & White, W.F. (1991) Opioid receptors localize to the external granular cell layer of the developing human cerebellum. Neuroscience, 45, 13-21.
49. Knapp, P.E., Maderspach, K. & Hauser, K.F. (1998) Endogenous opioid system in developing normal and jimpy oligodendrocytes: μ and κ opioid receptors mediate differential mitogenic and growth responses. Glia, 22, 189-201.
50. Kornblum, H.I., Loughlin, S.E. & Leslie, F.M. (1987) Effects of morphine on DNA synthesis in neonatal rat brain. Dev. Brain Res., 31, 45-52.
51. Korr, H. (1980) Proliferation of different cell types in the brain. Adv. Anat., Embryol., Cell Biol., 61, 1-72.
52. Kreek, M.J. & Koob, G.F. (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend., 51, 23-47.
53. Kuhn, C., Ignar, D. & Windh, R. (1991) Endocrine function as a target of perinatal drug effects: methodological issues. In Kilbey, M.M. & Asghar, K. (eds), Methodological Issues in Controlled Studies on the Effects of Prenatal Exposure to Drug Abuse. NIDA Res. Monog, Vol. 114. USPHS, NIDA, Rockville, MD, pp. 206-232.
54. Law, P.Y. & Bergsbaken, C. (1995) Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. J. Pharmacol. Exp. Ther., 272, 322-332.
55. Lee, Y.S. & Wurster, R.D. (1994) Differential effects of methionine enkephalin on the growth of brain tumor cells. J. Neurooncol., 19, 11-15.
56. Leslie, F.M., Chen, Y. & Winzer-Serhan, U.H. (1998) Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can. J. Physiol Pharmacol., 76, 284-293.
57. Leslie, F.M. & Loughlin, S.E. (1993) Ontogeny and plasticity of opioid systems. In Hammer, R.P. Jr (ed.), The Neurobiology of Opiates. CRC Press, Boca Raton, FL, pp. 85-123.
58. Maneckjee, R. & Minna, J.D. (1990) Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl Acad. Sci. USA, 87, 3294-3298.
59. Mangoura, D. (1997) mu-Opioids activate tyrosine kinase focal adhesion kinase and regulate cortical cytoskeleton proteins cortactin and vinculin in chick embryonic neurons. J. Neurosci. Res., 50, 391-401.
60. Mangoura, D. & Dawson, G. (1993) Opioid peptides activate phospholipase D and protein kinase C-ε in chicken embryo neuron cultures. Proc. Natl Acad. Sci. USA, 90, 2915-2919.
61. Mansour, A., Fox, C.A., Burke, S., Meng, F., Thompson, R.C., Akil, H. & Watson, S.J. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol., 350, 412-438.
62. McDowell, J. & Kitchen, I. (1987) Development of opioid systems: peptides, receptors, and pharmacology. Brain Res. Rev., 12, 397-421.
63. Meriney, S.D., Ford, M.J., Oliva, D. & Pilar, G. (1991) Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J. Neurosci., 11, 3705-3717.
64. Meriney, S.D., Gray, D.B. & Pilar, G. (1985) Morphine-induced delay of normal cell death in the avian ciliary ganglion. Science, 228, 1451-1453.
65. Miale, I.L. & Sidman, R.L. (1961) An autoradiographic analysis of histogenesis in the mouse cerebellum. Exp. Neurol., 4, 277-296.
66. Millan, M.J. & Herz, A. (1985) The endocrinology of opioids. Int. Rev. Neurobiol., 26, 1-83.
67. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J. & Burks, T.F. (1983) Bis-penicillamine enkephalins show pronounced delta enkephalin selectivity. Proc. Natl Acad. Sci. USA, 80, 5871-5880.
68. Mullaney, I., Carr, I.C., Burt, A.R., Wilson, M., Anderson, N.G. & Milligan, G. (1997) Agonist-mediated tyrosine phosphorylation of isoforms of the shc adapter protein by the delta opioid receptor. Cell Signal., 9, 423-429.
69. Nestler, E.J. (1996) Under siege: the brain on opiates. Neuron, 16, 897-900.
70. Opanashuk, L.A. & Hauser, K.F. (1998) Opposing actions of the EGF family and opioids: heparin binding-epidermal growth factor (HB-EGF) protects mouse cerebellar neuroblasts against the antiproliferative effect of morphine. Brain Res., 804, 87-94.
71. Osborne, J.G., Kindy, M.S., Spruce, B.A. & Hauser, K.F. (1993) Ontogeny of proenkephalin mRNA and enkephalin peptide expression in the cerebellar cortex of the rat: spatial and temporal patterns of expression follow maturational gradients in the external granular layer and in Purkinje cells. Dev. Brain Res., 76, 1-12.
72. Pan, E.C., Bohn, L.M., Belcheva, M.M., Thomas, G.E., Manepalli, A.N., Mamone, J.Y., Johnson, F.E. & Coscia, C.J. (1998) Kappa-opioid receptor binding varies inversely with tumor grade in human gliomas. Cancer, 83, 2561-2566.
73. Panagiotou, S., Hatzoglou, A., Calvo, F., Martin, P.M. & Castanas, E. (1998) Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems. J. Cell Biochem., 71, 416-428.
74. Pasto, M.E., Graziani, L.J., Tunis, S.L., Deiling, J.M., Kurtz, A.B., Goldberg, B. & Finnegan, L.P. (1993) Ventricular configuration and cerebral growth in infants born to drug-dependent mothers. Pediatr. Radiol. 1985, 15, 77-81.
75. Polakiewicz, R.D., Schieferl, S.M., Gingras, A.C., Sonenberg, N. & Comb, M.J. (1998) mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J. Biol. Chem., 273, 23534-23541.
76. Raetzman, L.T. & Siegel, R.E. (1999) Immature granule neurons from cerebella of different ages exhibit distinct developmental potentials. J. Neurobiol., 38, 559-570.
77. Ramón y Cajal. S. (1960) Studies on Vertebrate Neurogenesis. Charles C. Thomas, Springfield, IL, USA.
78. Reznikov, K., Hauser, K.F., Nazarevskaja, G., Trunova, Y., Derjabin, V. & Bakalkin, G. (1999) Opioids modulate cell division in the germinal zone of the late embryonic neocortex. Eur. J. Neurosci., 11, 2711-2719.
79. Rosen, H. & Bar-Shavit, Z. (1994) Dual role of osteoblastic proenkephalin derived peptides in skeletal tissues. J. Cell. Biochem., 55, 334-339.
80. Rossi, G.C., Su, W., Leventhal, L., Su, H. & Pasternak, G.W. (1997) Antisense mapping DOR-1 in mice: further support for delta receptor subtypes. Brain Res., 753, 176-179.
81. Sakellaridis, N. & Vernadakis, A. (1986) An unconventional response of adenylate cyclase to morphine and naloxone in the chicken during early development. Proc. Natl Acad. Sci. USA, 83, 2738-2742.
82. Sharp, B.M., Roy, S. & Bidlack, J.M. (1998) Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol., 83, 45-56.
83. Sholl, D.A. (1953) Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. (Lond.), 87, 387-407.
84. Sklair-Tavron, L., Shi, W.X., Lane, S.B., Harris, H.W., Bunney, B.S. & Nestler, E.J. (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl Acad. Sci. USA, 93, 11202-11207.
85. Spruce, B.A., Curtis, R., Wilkin, G.P. & Glover, D.M. (1990) A neuropeptide precursor in cerebellum: proenkephalin exists in subpopulations of both neurons and astrocytes. EMBO J., 9, 1787-1795.
86. Tecott, L.H., Rubenstein, J.L.R., Paxinos, G., Evans, C.J., Eberwine, J.H. & Valentino, K.L. (1989) Developmental expression of proenkephalin mRNA and peptides in rat striatum. Dev. Brain Res., 49, 75-86.
87. Vernadakis, A., Estin, C., Gibson, D.A. & Amott, S. (1982) Effects of methadone on ornithine decarboxylase and cyclic nucleotide phosphohydrolase in neuronal and glial cell cultures. J. Neurosci. Res., 7, 111-117.
88. 5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci., 31, 119-126.
89. Volkmar, F.R. & Greenough, W.T. (1972) Rearing complexity affects branching of cortical dendrites in the visual cortex of the rat. Science, 176, 1445-1447.
90. Walker, J.J. & King, J.S. (1989) Ontogenesis of enkephalinergic afferent systems in the opossum cerebellum. Dev. Brain Res., 48, 35-58.
91. Wilkinson, K.D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J.M. & Pohl, J. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science, 246, 670-673.
92. 7. Neuroscience, 9, 563-586.
93. 85s6k S6 kinase. Biochem. J., 325, 217-222.
94. Wood, K.A., Dipasquale, B. & Youle, R.J. (1993) In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron, 11, 621-632.
95. Yang, X.W., Zhong, R. & Heintz, N. (1996) Granule cell specification in the developing mouse brain as defined by expression of the zinc finger transcription factor RU49. Development, 122, 555-566.
96. Yeadon, M. & Kitchen, I. (1989) Opioids and respiration. Prog. Neurobiol., 33, 1-16.
97. Zadina, J.E., Hackler, L., Ge, L.J. & Kastin, A.J. (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature, 386, 499-502.
98. Zagon, I.S., Gibo, D.M. & McLaughlin, P.J. (1992) Ontogeny of zeta (ζ), the opioid growth factor receptor, in the rat brain. Brain Res., 596, 149-156.
99. Zagon, I.S. & McLaughlin, P.J. (1983) Increased brain size and cellular content in infant rats treated with an opioid antagonist. Science, 221, 1179-1180.
100. Zagon, I.S. & McLaughlin, P.J. (1986) Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies. J. Neurosci., 6, 1424-1432.
101. Zagon, I.S. & McLaughlin, P.J. (1987) Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res., 412, 68-72.
102. Zagon, I.S. & McLaughlin, P.J. (1991) Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res., 542, 318-323.
103. Zagon, I.S., Rhodes, R.E. & McLaughlin, P.J. (1985) Distribution of enkephalin immunoreactivity in germinative cells of developing rat cerebellum. Science, 227, 1049-1051.
104. Zamboni, L. & De Martino, C. (1967) Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy. J. Cell Biol., 35, 148A.
105. Zhang, L. & Goldman, J.E. (1996) Generation of cerebellar interneurons from dividing precursors in white matter. Neuron, 16, 47-54.
106. Zhu, Y., Hsu, M.S. & Pintar, J.E. (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J. Neurosci., 18, 2538-2549.